Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.80
-0.10 (-0.36%)
At close: Apr 29, 2026

Formosa Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
4,1973,9865,6546,7005,9213,390
Upgrade
Market Cap Growth
-4.14%-29.51%-15.62%13.17%74.66%-
Upgrade
Enterprise Value
2,7832,4994,0175,4725,8002,937
Upgrade
Last Close Price
27.8026.4037.4549.9550.5932.95
Upgrade
PS Ratio
442.04419.7839.44214.954502.47118.82
Upgrade
PB Ratio
2.882.743.655.8812.678.62
Upgrade
P/TBV Ratio
4.224.014.698.77105.56-
Upgrade
EV/Sales Ratio
293.09263.2128.02175.534410.71102.95
Upgrade
Debt / Equity Ratio
0.020.020.020.030.020.01
Upgrade
Net Debt / Equity Ratio
-0.97-0.97-1.05-1.04-0.89-0.52
Upgrade
Net Debt / EBITDA Ratio
11.0211.0211.574.791.200.60
Upgrade
Net Debt / FCF Ratio
13.3913.3911.925.991.200.62
Upgrade
Asset Turnover
0.010.010.080.020.000.05
Upgrade
Inventory Turnover
3.143.14----
Upgrade
Quick Ratio
8.828.828.574.896.2611.55
Upgrade
Current Ratio
9.119.118.734.996.5612.15
Upgrade
Return on Equity (ROE)
-5.56%-5.56%-14.94%-40.04%-94.39%-135.15%
Upgrade
Return on Assets (ROA)
-5.10%-5.10%-5.72%-13.58%-30.45%-41.28%
Upgrade
Return on Capital Employed (ROCE)
-9.00%-9.00%-9.20%-19.30%-47.20%-56.80%
Upgrade
Earnings Yield
-1.99%-2.10%-3.55%-4.81%-6.86%-11.83%
Upgrade
FCF Yield
-2.52%-2.65%-2.40%-2.96%-5.85%-9.78%
Upgrade
Buyback Yield / Dilution
-7.22%-7.22%-13.48%-18.00%-13.70%-31.19%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.